Company
Elucidata
High - Quality Biological Data Systems for Drug Discovery
Also known as Elucidata Corporation
- Business model
- B2B
- Legal name
- Elucidata Corporation
Claim, correct or request removal
Record updated 29 September 2026
About
Elucidata helps pharma and biotech teams turn fragmented biological data into high-quality, structured systems - accelerating biomarker discovery, advancing target identification, and driving real progress in drug development.
Funding snapshot
- Total raised
- $2.6MSEC form D sum, as of 2026-09-29Source (opens in a new tab)
- Latest round
- Round, $880K2020-07-10
Funding rounds
- Round, 2020
- $880K2020-07-10, SEC form D sold, 10 investors
- Round, 2018
- $1.7M2018-05-09, SEC form D sold, 16 investors
Loading relationship preview